Substantial progresses have been achieved in the treatment of APL since introduction of the use of ATRA in the middle of eighty and ATO from 2000.Its CR rate wa
Since the introduction of all-trans-retinoic acid (ATRA), the use of this molecularly targeted treatment in combination with anthracycline-based chemotherapy ha